These results indicate that mammals have evolved an effective defense mechanism against oncogenic K-Ras mutations, and the mechanism is abrogated in colorectal cancer through Apc inactivation, which induces the formation of colorectal ADs. Here, KRAS is linked to colorectal cancer.